The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Role of STAT3 in Cancer Metastasis and Translational Advances
Open accessAbstract
Signal transducer and activator of transcription 3 (STAT3) is a latent cytoplasmic transcription factor, originally discovered as a transducer of signal from cell surface receptors to the nucleus. It is activated by tyrosine phosphorylation at position 705 leading to its dimerization, nuclear translocation, DNA binding, and activation of gene transcription. Under normal physiological conditions, STAT3 activation is tightly regulated. However, compelling evidence suggests that STAT3 is constitutively activated in many cancers and plays a pivotal role in tumor growth and metastasis. It regulates cellular proliferation, invasion, migration, and angiogenesis that are critical for cancer metastasis. In this paper, we first describe the mechanism of STAT3 regulation followed by how STAT3 is involved in cancer metastasis, then we summarize the various small molecule inhibitors that inhibit STAT3 signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“STAT3 has also been reported to induce expression of hypoxia-inducible factor1α (HIF1α), another key mediator of angiogenesis [80].”
BackgroundDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 2×
“…August 2013; Accepted 26 August 2013 Academic Editor: Jeroen T. Buijs Copyright © 2013 Mohammad Zahid Kamran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the…”
BackgroundCancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 1×
“Jang and coworkers reported that resveratrol treatment inhibited the development of preneoplastic lesions in carcinogen-treated mouse mammary glands in culture and tumorigenesis in a mouse skin cancer model [97].”
BackgroundSTATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · cited 1×
“Several studies suggested that inhibition of STAT3 activation promotes the release of proinflammatory cytokines, while a mutant having constitutively active STAT3 in fibroblasts suppressed the LPS induced pro-inflammatory response [70, 83–85].”
BackgroundDarnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743 · cited 1×
“Among sevenmammalian STAT proteins, persistent activation of STAT3 followed by STAT5 is frequently detected in majority of human cancer cell lines and tumor tissues [9, 10].”
Backgroundc-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408 · cited 1×
“Studies by Lee and coworkers demonstrated that flavopiridol disrupts STAT3/DNA interaction, attenuates STAT3 directed transcription, and downregulates Mcl1, an antiapoptotic protein present downstream of STAT3 [104].”
BackgroundConstitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,185
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
Verstovsek, S., Kantarjian, H., Mesa, R. A., Pardanani, A. D., Cortes-Franco, J., Thomas, D. A., Estrov, Z., Fridman, J. S., Bradley, E. C., Erickson-Viitanen, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002028 · Cited by 1,164
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Structural identification of autoinducer of Photobacterium fischeri luciferase
Eberhard, A., Burlingame, A. L., Eberhard, C., Kenyon, G. L., Nealson, K. H., & Oppenheimer, N. J. (1981) · Biochemistry · doi:10.1021/bi00512a013 · Cited by 986
Specific Inhibition of Stat3 Signal Transduction by PIAS3
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997) · Science · doi:10.1126/science.278.5344.1803 · Cited by 980 · cited 2×
“It has been proposed that PIAS1, PIAS3 and PIASx interact with STAT1, STAT3, and STAT4 respectively [32, 33, 35].”
BackgroundEnhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Hoessel, R., Leclerc, S., Endicott, J. A., Nobel, M. E. M., Lawrie, A., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., et al. (1999) · Nature Cell Biology · doi:10.1038/9035 · Cited by 809
Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue
Yuan, Z.-L., Guan, Y.-J., Chatterjee, D., & Chin, Y. E. (2005) · Science · doi:10.1126/science.1105166 · Cited by 790 · cited 2×
“Additionally, STAT3 is also acetylated on a single lysine residue located at position 685 by histone acetyl transferase p300 [21].”
BackgroundInhibition of Stat1-mediated gene activation by PIAS1
Liu, B., Liao, J., Rao, X., Kushner, S. A., Chung, C. D., Chang, D. D., & Shuai, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10626 · Cited by 765
Protein tyrosine phosphatases in signal transduction
Neel, B. G., & Tonks, N. K. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80063-4 · Cited by 753
Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains
Andersen, J. N., Mortensen, O. H., Peters, G. H., Drake, P. G., Iversen, L. F., Olsen, O. H., Jansen, P. G., Andersen, H. S., Tonks, N. K., & Møller, N. P. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7117-7136.2001 · Cited by 715
The Stat family in cytokine signaling
Ihle, J. N. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00199-x · Cited by 713 · cited 1×
“All seven human STAT proteins range between 750 and 850 amino acids and are located on three chromosomal clusters [3, 5, 6].”
BackgroundStat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
Blaskovich, M. A., Sun, J., Cantor, A. B., Turkson, J., Jove, R., & Sebti, S. M. (2003) · PubMed · Cited by 643
Zhang, J.-G., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R., Hausmann, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2071 · Cited by 627
Chung, J., Uchida, E., Grammer, T. C., & Blenis, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6508 · Cited by 620
SOCS regulation of the JAK/STAT signalling pathway
Croker, B. A., Kiu, H., & Nicholson, S. E. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.010 · Cited by 611
Xu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., Gritsko, T., Turkson, J., Kay, H., Semenza, G. L., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208719 · Cited by 576
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
Irie-Sasaki, J., Sasaki, T., Matsumoto, W., Opavsky, A., Cheng, M., Welstead, G., Griffiths, E., Krawczyk, C., Richardson, C. D., Aitken, K., et al. (2001) · Nature · doi:10.1038/35053086 · Cited by 562
Wei, D., Le, X., Zheng, L., Wang, L., Frey, J. A., Gao, A. C., Peng, Z., Huang, S., Xiong, H. Q., Abbruzzese, J. L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206122 · Cited by 558
Xie, T.-X., Wei, D., Liu, M., Gao, A. C., Ali-Osman, F., Sawaya, R., & Huang, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207383 · Cited by 550
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Hedvat, M., Huszar, D., Herrmann, A., Gozgit, J. M., Schroeder, A., Sheehy, A., Buettner, R., Proia, D., Kowolik, C. M., Xin, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.015 · Cited by 526
Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S., & Takeda, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4657 · Cited by 519
Bharti, A. C., Donato, N., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3863 · Cited by 508
Song, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504
Ilaria, R. L., & Van Etten, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31704 · Cited by 488
Chapman, R. S., Lourenco, P. C., Tonner, E., Flint, D. J., Selbert, S., Takeda, K., Akira, S., Clarke, A. R., & Watson, C. J. (1999) · Genes & Development · doi:10.1101/gad.13.19.2604 · Cited by 479
Yokogami, K., Wakisaka, S., Avruch, J., & Reeves, S. A. (2000) · Current Biology · doi:10.1016/s0960-9822(99)00268-7 · Cited by 469
Regulation of gene-activation pathways by PIAS proteins in the immune system
Shuai, K., & Liu, B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1667 · Cited by 447
Garcia, R., Yu, C., Hudnall, A. M., Catlett, R., Nelson, K. L., Smithgall, T. E., Fujita, D. J., Ethier, S. P., & Jove, R. (1997) · PubMed · Cited by 441
Synergistic Roles for Pim-1 and c-Myc in STAT3-Mediated Cell Cycle Progression and Antiapoptosis
Shirogane, T., Fukada, T., Muller, J. M. M., Shima, D. T., Hibi, M., & Hirano, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80145-4 · Cited by 426
Bhardwaj, A., Sethi, G., Vadhan-Raj, Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A. S., Shishodia, S., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-02-003988 · Cited by 395
Role of Stat3 in Regulating p53 Expression and Function
Niu, G., Wright, K. L., Ma, Y., Wright, G. M., Huang, M., Irby, R., Briggs, J., Karras, J., Cress, W. D., Pardoll, D., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7432-7440.2005 · Cited by 392
Modulation of STAT signaling by STAT-interacting proteins
Shuai, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203522 · Cited by 379 · cited 2×
“Other conserved elements of PIAS proteins include zinc binding domain, acidic domain, and serine/threonine rich regions; however, PIASy lacks serine/threonine rich domain [31].”
BackgroundSTAT3 as a central mediator of neoplastic cellular transformation
Frank, D. A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.10.017 · Cited by 364
Niu, G., Heller, R. F., Catlett-Falcone, R., Coppola, D., Jaroszeski, M. J., Dalton, W. S., Jove, R., & Yu, H. (1999) · PubMed · Cited by 363
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
Leong, P. L., Andrews, G. A., Johnson, D. E., Dyer, K. F., Xi, S., Mai, J. C., Robbins, P. D., Gadiparthi, S., Burke, N. A., Watkins, S. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0534764100 · Cited by 340
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway
de la Iglesia, N., Konopka, G., Puram, S. V., Chan, J. A., Bachoo, R. M., You, M. J., Levy, D. E., DePinho, R. A., & Bonni, A. (2008) · Genes & Development · doi:10.1101/gad.1606508 · Cited by 336
Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular Carcinogenesis
Bard-Chapeau, E. A., Li, S., Ding, J., Zhang, S. S., Zhu, H. H., Princen, F., Fang, D. D., Han, T., Bailly-Maitre, B., Poli, V., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.023 · Cited by 332
Wen, Z. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.11.2062 · Cited by 325
Sen, M., Thomas, S. M., Kim, S., Yeh, J. I., Ferris, R. L., Johnson, J. T., Duvvuri, U., Lee, J., Sahu, N., Joyce, S., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0191 · Cited by 313
STAT3: A critical transcription activator in angiogenesis
Chen, Z., & Han, Z. C. (2008) · Medicinal Research Reviews · doi:10.1002/med.20101 · Cited by 305
Regulation of STAT‐dependent pathways by growth factors and cytokines
Leaman, D. W., Leung, S., Li, X., & Stark, G. R. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.14.9002549 · Cited by 297
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells
Nam, S., Buettner, R., Turkson, J., Kim, D., Cheng, J. Q., Muehlbeyer, S., Hippe, F., Vatter, S., Merz, K.-H., Eisenbrand, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409467102 · Cited by 294
Bhattacharya, S., Ray, R. M., & Johnson, L. R. (2005) · Biochemical Journal · doi:10.1042/bj20050465 · Cited by 291
Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
Quintás-Cardama, A., Kantarjian, H., Cortes, J., & Verstovsek, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3264 · Cited by 290
Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K., Khaled, A., Zervos, A. S., Carter, B., Turkson, J., & Jove, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0268 · Cited by 283
Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin
Ng, D. C. H., Lin, B. H., Lim, C. P., Huang, G., Zhang, T., Poli, V., & Cao, X. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200503021 · Cited by 278
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity
Sun, J., Blaskovich, M. A., Jove, R., Livingston, S. K., Coppola, D., & Sebti, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208470 · Cited by 263
Turkson, J., Bowman, T., Adnane, J., Zhang, Y., Djeu, J. Y., Sekharam, M., Frank, D. A., Holzman, L. B., Wu, J., Sebti, S., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7519 · Cited by 258
Dechow, T. N., Pedranzini, L., Leitch, A., Leslie, K., Gerald, W. L., Linkov, I., & Bromberg, J. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404100101 · Cited by 254
Activated Signal Transducer and Activator of Transcription (STAT) 3
Silver, D. L., Naora, H., Liu, J., Cheng, W., & Montell, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3959 · Cited by 252
Huang, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2313 · Cited by 249
Grunstein, J., Roberts, W. G., Mathieu-Costello, O. A., Hanahan, D., & Johnson, R. S. (1999) · PubMed · Cited by 247
Arguello, F., Alexander, M., Sterry, J. A., Tudor, G., Smith, E. M., Kalavar, N. T., Greene, J. F., Koss, W., Morgan, C. D., Stinson, S. F., et al. (1998) · PubMed · doi:10.1182/blood.v91.7.2482 · Cited by 240
Mechanisms of action of flavopiridol
Sedlacek, H. H. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00124-4 · Cited by 239
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K.-I., Sata, M., Kohara, M., & Yoshimura, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012127 · Cited by 236
Ni, Z., Lou, W., Leman, E. S., & Gao, A. C. (2000) · PubMed · Cited by 232
Tumour escape from immune surveillance through dendritic cell inactivation
Vicari, A. P., Caux, C., & Trinchieri, G. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0400 · Cited by 228
McCarty, O. J. T., Mousa, S. A., Bray, P. F., & Konstantopoulos, K. (2000) · Blood · doi:10.1182/blood.v96.5.1789 · Cited by 223
Nielsen, M., Kaltoft, K., Nordahl, M., Röpke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A., & Ødum, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6764 · Cited by 220
STAT3 is constitutively activated in Hodgkin cell lines
Kube, D., Holtick, U., Vockerodt, M., Ahmadi, T., Haier, B., Behrmann, I., Heinrich, P. C., Diehl, V., & Tesch, H. (2001) · Blood · doi:10.1182/blood.v98.3.762 · Cited by 218
A transcriptional corepressor of Stat1 with an essential LXXLL signature motif
Liu, B., Gross, M., ten Hoeve, J., & Shuai, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051489598 · Cited by 208
Protein Kinase C δ Associates with and Phosphorylates Stat3 in an Interleukin-6-dependent Manner
Jain, N., Zhang, T., Kee, W. H., Li, W., & Cao, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24392 · Cited by 201
Distribution of the Mammalian Stat Gene Family in Mouse Chromosomes
Copeland, N. G., Gilbert, D. J., Schindler, C., Zhong, Z., Wen, Z., Darnell, J. E., Mui, A. L.-F., Miyajima, A., Quelle, F. W., Ihle, J. N., et al. (1995) · Genomics · doi:10.1006/geno.1995.1235 · Cited by 199
Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice
Zhang, L., Alizadeh, D., Van Handel, M., Kortylewski, M., Yu, H., & Badie, B. (2009) · Glia · doi:10.1002/glia.20863 · Cited by 191
Turkson, J., Zhang, S., Palmer, J., Kay, H., Stanko, J., Mora, L. B., Sebti, S., Yu, H., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1533.3.12 · Cited by 188
Yahata, Y., Shirakata, Y., Tokumaru, S., Yamasaki, K., Sayama, K., Hanakawa, Y., Detmar, M., & Hashimoto, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301866200 · Cited by 183
Han, Y., Amin, H. M., Franko, B., Frantz, C., Shi, X., & Lai, R. (2006) · Blood · doi:10.1182/blood-2006-04-017434 · Cited by 179
The function of Stat3 in tumor cells and their microenvironment
Groner, B., Lucks, P., & Borghouts, C. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.06.005 · Cited by 174
De Vos, J., Jourdan, M., Tarte, K., Jasmin, C., & Klein, B. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02127.x · Cited by 172
Xi, S., Gooding, W. E., & Grandis, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208316 · Cited by 170
Turkson, J., Zhang, S., Mora, L. B., Burns, A. C., Sebti, S. M., & Jove, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502694200 · Cited by 169
Wung, B., Hsu, M. C., Wu, C., & Hsieh, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.052 · Cited by 167
Itoh, M., Murata, T., Suzuki, T., Shindoh, M., Nakajima, K., Imai, K., & Yoshida, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209149 · Cited by 166
PIASx Is a Transcriptional Co-repressor of Signal Transducer and Activator of Transcription 4
Arora, T., Liu, B., He, H., Kim, J. J., Murphy, T. L., MURPHY, K. M. M., Modlin, R. L., & Shuai, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300119200 · Cited by 166
VEGF differentially activates STAT3 in microvascular endothelial cells
Bartoli, M., Platt, D. H., Lemtalsi, T., Gu, X., Brooks, S. E., Marrero, M. B., & Caldwell, R. B. (2003) · The FASEB Journal · doi:10.1096/fj.02-1084fje · Cited by 161
Li, L., Hooi, D. S. W., Chhabra, S. R., Pritchard, D., & Shaw, P. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207612 · Cited by 155
Azare, J., Leslie, K., Al‐Ahmadie, H. A., Gerald, W. L., Weinreb, P. H., Violette, S. M., & Bromberg, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02404-06 · Cited by 155
Yang, Y., Chang, Y., Huang, P., Chiou, G., Tseng, L., Chiou, S., Chen, M., Chen, M., Shih, Y., Chang, C., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22806 · Cited by 148
A Role of STAT3 in Rho GTPase-regulated Cell Migration and Proliferation
Debidda, M., Wang, L., Zang, H., Poli, V., & Zheng, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413187200 · Cited by 147
Mackenzie, G. G., Queisser, N., Wolfson, M. L., Fraga, C. G., Adamo, A. M., & Oteiza, P. I. (2008) · International Journal of Cancer · doi:10.1002/ijc.23477 · Cited by 144
Chen, Y., Chen, K.-H., Huang, P., Chen, Y., Chiou, G.-Y., Lo, W., Tseng, L., Hsu, H.-S., Chang, K., & Chiou, S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0504 · Cited by 138
Glienke, W., Maute, L., Wicht, J., & Bergmann, L. (2009) · Cancer Investigation · doi:10.3109/07357900903287006 · Cited by 125
Chakravarti, N., Myers, J. N., & Aggarwal, B. B. (2006) · International Journal of Cancer · doi:10.1002/ijc.21967 · Cited by 124
Dai, Y., Rahmani, M., Pei, X., Dent, P., & Grant, S. (2004) · Blood · doi:10.1182/blood-2003-12-4121 · Cited by 124
Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma
Shahab Uddin, M. S., Hussain, A. R., Manogaran, P. S., Al‐Hussein, K., Platanias, L. C., Gutiérrez, M. I., & Bhatia, K. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208864 · Cited by 123
Small Molecule Inhibitors of Stat3 Signaling Pathway
Deng, J. N., Grande, F., & Neamati, N. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006922 · Cited by 121
Bill, M. A., Fuchs, J. R., Li, C., Yui, J. C., Bakan, C. E., Benson, D. M., Schwartz, E. B., Abdelhamid, D. S., Lin, J., Hoyt, D. G., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-165 · Cited by 121
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
Zhang, X., Zhang, J., Wang, L., Wei, H., & Tian, Z. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-149 · Cited by 116
Holtick, U., Vockerodt, M., Pinkert, D., Schoof, N., Stürzenhofecker, B., Kussebi, N., Lauber, K., Wesselborg, S., Löffler, D., Horn, F., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403750 · Cited by 111
6-Bromoindirubin-3′-Oxime Inhibits JAK/STAT3 Signaling and Induces Apoptosis of Human Melanoma Cells
Liu, L., Nam, S., Tian, Y., Yang, F., Wu, J., Wang, Y., Scuto, A., Polychronopoulos, P., Magiatis, P., Skaltsounis, A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3852 · Cited by 110
Stat3 promotes directional cell migration by regulating Rac1 activity via its activator βPIX
Teng, T., Lin, B., Manser, E., Ng, D. C. H., & Cao, X. (2009) · Journal of Cell Science · doi:10.1242/jcs.057109 · Cited by 107
Suiqing, C., Min, Z., & Lirong, C. (2005) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2005.tb00906.x · Cited by 102
Regulation of Angiotensin II-induced Phosphorylation of STAT3 in Vascular Smooth Muscle Cells
Liang, H., Venema, V. J., Wang, X., Ju, H., Venema, R. C., & Marrero, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19846 · Cited by 95
The tumor cell–host organ interface in the early onset of metastatic organ colonisation
Gaßmann, P., & Haier, J. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9130-6 · Cited by 94
Choudhari, S. R., Khan, M. A., Harris, G., Picker, D., Jacob, G. S., Block, T., & Shailubhai, K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0561 · Cited by 90 · cited 1×
“Choudhari and coworkers have shown that atiprimod inhibits protein kinase B (Akt) and STAT3 signaling, thereby inhibiting proliferation and inducing apoptosis in hepatocellular carcinoma [135].”
BackgroundSeo, J. H., Jeong, K. J., Oh, W. J., Sul, H. J., Sohn, J. S., Kim, Y. K., Cho, D. Y., Kang, J., Park, C. G., & Lee, H. Y. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.023 · Cited by 90
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells
Amit-Vazina, M., Shishodia, S., Harris, D., Van, Q., Wang, M., Weber, D., Alexanian, R., Talpaz, M., Aggarwal, B. B., & Estrov, Z. E. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602637 · Cited by 89
Physiological significance of STAT proteins: investigations through gene disruption in vivo
Levy, D. E. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050395 · Cited by 87
Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells
Blasius, R., Reuter, S., Henry, E., Dicato, M. A., & Diederich, M. F. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.029 · Cited by 86
Inhibition of STAT3 Expression and Signaling in Resveratrol-Differentiated Medulloblastoma Cells
Li-jun, Y., Wu, M., Li, H., Chen, X.-Y., Wang, Q., Sun, Y., Kong, Q., & Liu, J. (2008) · Neoplasia · doi:10.1593/neo.08304 · Cited by 83
Kojima, H., Sasaki, T., Ishitani, T., Iemura, S.-I., Zhao, H., Kaneko, S., Kunimoto, H., Natsume, T., Matsumoto, K., & Nakajima, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500679102 · Cited by 81
Iwanski, G. B., Lee, D. H., Ein-Gal, S. Y., Doan, N., Castor, B., Vogt, M., Toh, M., Bokemeyer, C., SAID, J. W., Thoennissen, N. H., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00741.x · Cited by 79
Chen, W., Daines, M., & Hershey, G. K. K. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.042 · Cited by 77
Qiu, Z., Huang, C., Sun, J., Qiu, W., Zhang, J., Li, H., Jiang, T., Huang, K., & Cao, J. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00485.x · Cited by 77
Li, H., Huang, C., Huang, K., Wu, W. D., Jiang, T., Cao, J., Feng, Z., & Qiu, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025941 · Cited by 69
Hwang, J. H., Kim, D. W., Suh, J. M., Kim, H., Song, J. H., Hwang, E. S., Park, K. C., Chung, H. K., Kim, J., Lee, T., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0401 · Cited by 68
Oh, M., Park, H., Kim, N., Park, S., Park, I. Y., & Kim, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.150557 · Cited by 66
Inactivation of Stat3 in tumor cells
Gamero, A. M., Young, H. A., & Wiltrout, R. H. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00028-5 · Cited by 65
Zhen, Y., Sørensen, V., Jin, Y., Suo, Z., & Więdłocha, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210473 · Cited by 64
Lee, Y. K., Isham, C. R., Kaufmann, S. H., & Bible, K. C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0235 · Cited by 64
Stat3 Is Required for Full Neoplastic Transformation by the Simian Virus 40 Large Tumor Antigen
Vultur, A., Arulanandam, R., Turkson, J., Niu, G., Jove, R., & Raptis, L. H. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-12-1104 · Cited by 59
Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway
Kamran, M. Z., & Gude, R. P. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.03.020 · Cited by 50
Self-citationWang, M. L., Zhang, L., Han, X., Yang, J., Qian, J., Hong, S., Samaniego, F., Romaguera, J. E., & Yi, Q. (2007) · Blood · doi:10.1182/blood-2006-12-063958 · Cited by 44
Faderl, S. H., Ferrajoli, A., Harris, D., Van, Q., Kantarjian, H. M., & Estrov, Z. E. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.05.027 · Cited by 43
Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo.
Shen, J., Li, R., & Li, G. (2009) · PubMed · Cited by 42
Yu, C.-Y., Wang, L., Khaletskiy, A., Farrar, W. L., Larner, A. C., Colburn, N. H., & Li, J. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205499 · Cited by 41
LMW-PTP associates and dephosphorylates STAT5 interacting with its C-terminal domain
Rigacci, S., Talini, D., & Berti, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.126 · Cited by 37
Kamran, M. Z., & Gude, R. P. (2012) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2012.03.006 · Cited by 33
Self-citationActivation of Stat3 Transcription Factor by Herpesvirus Saimiri STP-A Oncoprotein
Chung, Y.-H., Cho, N., Garcia, M. I., Lee, S. H., Feng, P., & Jung, J. U. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6489-6497.2004 · Cited by 29
Role of STAT3 in In Vitro Transformation Triggered by TRK Oncogenes
Miranda, C., Fumagalli, T., Anania, M. C., Vizioli, M. G., Pagliardini, S., Pierotti, M. A., & Greco, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009446 · Cited by 26
Modulation of Janus kinase 2 by cisplatin in cancer cells
Song, H., Sondak, V. K., Barber, D. L., Reid, T., & Lin, J. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.4.1017 · Cited by 26
Cited by
Role of STAT3 signaling pathway in breast cancer
Ma, J.-H., Qin, L., & Li, X. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0527-z · Cited by 420
Chemotherapy: a double-edged sword in cancer treatment
Behranvand, N., Nasri, F., Zolfaghari Emameh, R., Khani, P., Hosseini, A., Garssen, J., & Falak, R. (2022) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-021-03013-3 · Cited by 397
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Qin, J.-J., Yan, L., Zhang, J., & Zhang, W.-D. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1206-z · Cited by 396
Targeting transcription factor STAT3 for cancer prevention and therapy
Chai, E. Z. P., Shanmugam, M. K., Arfuso, F., Dharmarajan, A., Wang, C., Kumar, A. P., Samy, R. P., Lim, L. H. K., Wang, L., Goh, B. C., et al. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.004 · Cited by 263
Napabucasin: an update on the first-in-class cancer stemness inhibitor
Hubbard, J. M., & Grothey, A. (2017) · Drugs · doi:10.1007/s40265-017-0759-4 · Cited by 157
Metadata
- Authors
- Kamran, M. Z., Patil, P., & Gude, R. P.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-15
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2036564735
- Cited by
- 393
- References
- 140
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.